ARTICLE | Distillery Therapeutics
Inflammation
November 13, 2018 10:50 PM UTC
In vitro and rat studies identified a pyrrolopyrimidine-based PI3Kδ inhibitor that could help treat asthma. Chemical synthesis and in vitro binding assays of pyrrolopyrimidine analogs yielded a compou...
BCIQ Company Profiles
BCIQ Target Profiles